Dr. Yasmin Thanavala on targeted therapy for liver cancer
2 Просмотры
• 06/28/23
0
0
встраивать
administrator
Подписчики
Yasmin Thanavala, PhD, of the Department of Immunology and the Tumor Immunology and Immunotherapy program at Roswell Park Cancer Institute, discusses new research that may help identify those patients with advanced liver cancer who will benefit most from the targeted therapy sorafenib. Read more: http://goo.gl/W0jPX2
Показать больше
Комментарии Facebook
SORT BY-
Лучшие комментарии
-
Последние комментарии